Literature DB >> 6253580

Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.

H Heath, D C Purnell.   

Abstract

FBH is characterized by symptomless hypercalcemia, low urinary calcium excretion, normal iPTH values, generally normal parathyroid histology, and failure of subtotal parathyroidectomy is normalize serum calcium. We studies six patients with FBH from three kindreds, six patients with sporadic 1 omicron HPT, and six healthy volunteers. To characterize the renal response to PTH, 14 of the subjects had infusions of bovine PTE (300 U intravenously over 15 min) and, separately, stimulation of endogenous PTH release by infusion of disodium EDTA (50 mg/kg over 2 hr). PTE induced striking increases of UcAMP (nM/100 ml of GF) that were indistinguishable between controls and subjects having FBH. However, the rise of UcAMP in 1 omicron HPT was significantly reduced (p < 0.001) compared to controls or the FBH group. EDTA-induced hypocalcemia raised serum iPTH and UcAMP in all three groups; the increases of iPTH (two assays of differing specificity) were greatest in 1 omicron HPT and least in FBH. In contrast, increases of UcAMP were greatest in FBH and 1 omicron HPT and indistinguishable from one another. The increase of UcAMP considered as a function of the increase in PTH showed significantly greater UcAMP responses in FBH than in the other groups. These results are consistent with primary or secondary alterations of renal responsiveness to PTH in both FBH and 1 omicron HPT, which may in part explain the different renal tubular calcium handling in the two conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253580

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

Review 1.  Familial hypocalciuric hypercalcaemia--familial benign hypercalcaemia: a review.

Authors:  J Auwerx; J Brunzell; R Bouillon; M Demedts
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

2.  Effects of secretory products of breast cancer cells on osteoblast-like cells.

Authors:  M Lacroix; B Siwek; J J Body
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Defective host defence mechanisms in a family with hypocalciuric hypercalcaemia and coexisting interstitial lung disease.

Authors:  J Auwerx; M Boogaerts; J L Ceuppens; M Demedts
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism.

Authors:  M F Attie; J R Gill; J L Stock; A M Spiegel; R W Downs; M A Levine; S J Marx
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Familial hypocalciuric hypercalcemia. Report of a new family.

Authors:  J M Gómez; S Jorge; J Soler; T Lucas
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

6.  Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin.

Authors:  J J Body; P E Cryer; K P Offord; H Heath
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.

Authors:  W M Law; H Heath
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.